Advancing Education in Cardiometabolic Disease

Register for This Live CME/CE Webinar Series,

choose from several convenient dates and times!

LDL-C Management & Risk Reduction in Clinical Practice: The Utility of PCSK9 Inhibitors.

Christie Ballantyne

Presented by:

Christie M. Ballantyne, MD

Professor of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine, Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Methodist DeBakey Heart Center
Houston, TX

Disclosures:
Grants/Research Support: Abbott Diagnostic, Amarin, Amgen, Eli Lilly, Esperion, Novartis, Pfizer, Otsuka, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, Takeda, NIH, AHA, ADA
Consulting Fees: Abbott Diagnostic, Amarin, Amgen, AstraZeneca, Eli Lilly, Esperion, Genzyme, ISIS, Matinas BioPharma Inc, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi-Synthelabo

Tuesday, March 28
7:00 – 8:00pm ET /
6:00 – 7:00pm CT